Â鶹´«Ã½¸ßÇå°æ

Rutika J Mehta, M.B., B.S.

Medical Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • Blue Access
  • EPO
  • HMO
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
Personal Statement

After my formal medical training, I left my home country to come to the United States in hopes of better education and training in the field. I was fortunate to meet several mentors who were nationally renowned scientists and physicians who helped expose me to the specialty area of oncology. Several of my life experiences over a span of almost a decade helped me realize my true calling to gastrointestinal oncology.  I have been fortunate to work with some great minds across diverse disciplines such as oncology, radiation oncology, surgical oncology, thoracic surgery, pathology and radiology. As a gastrointestinal (GI) medical oncologist, I look forward to caring for the different needs of patients and offer cutting-edge treatments for people with esophageal, gastric, liver, pancreatic, small bowel and colorectal cancers.

Biographical Info

Rutika Mehta MD, MPH is an Associate Professor in Medicine and Attending Physician at Â鶹´«Ã½¸ßÇå°æ and NewYork-Presbyterian Hospital. Dr. Mehta received her medical degree at Topiwala National Medical College in Mumbai, India. She subsequently completed a Masters in Public Health with a focus on Epidemiology at Indiana University, Indianapolis. She spent three years as a Research Fellow in the Department of Pathology at Indiana University School of Medicine. She then completed her training in Internal Medicine at Johns Hopkins University/Sinai Hospital of Baltimore followed by a fellowship in Hematology/Oncology at Roswell Park Comprehensive Cancer Institute in Buffalo, New York. After completing her hematology and oncology training, Dr. Mehta joined the gastrointestinal (GI) oncology department at the H. Lee Moffitt Cancer Center in Tampa, Florida. At Moffit Cancer Center, Dr. Mehta worked with many renowned leaders in the field and was instrumental in building the clinical and research program for upper GI malignancies. She was selected as a Castle Connolly “Top Doctor” for three straight years in the Tampa Bay area (2022-2024). Additionally, Dr. Mehta has had experience leading several clinical trials for GI cancer patients and has developed some novel trials herself. She is an active member of the American Society of Clinical Oncology (ASCO) and serves as a member of the National Cancer Institute (NCI) Taskforce for Esophagogastric Cancers. Dr. Mehta was recruited to Â鶹´«Ã½¸ßÇå°æ (WCM) in 2024. Her clinical and research efforts will focus on all GI cancers with a particular emphasis on developing clinical trials utilizing novel treatment options and advancing the field through precision medicine.

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Medical Oncology)
Clinical Expertise
Gastrointestinal Oncology
Colon Cancer
Colorectal Cancer
Esophageal Cancer
Liver Cancer
Gastric Cancer
Stomach Cancer
Pancreatic Cancer
Small Bowel Cancer
Languages
English
Hindi
Gujarati
Research
Education 
  • M.D.
    University of the State of New York
    2024
  • M.P.H.
    Indiana University School of Medicine
    2010
  • M.B.,B.S.
    Topiwala Medical College, University of Bombay (India)
    2007
Appointments 
  • Associate Attending Physician
    NewYork-Presbyterian Hospital
  • Associate Professor of Medicine (Pending Appointment at Rank)
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Other Interest: 
American Society of Clinical Oncology
Amgen, Inc.
Arcus Bioscience
Astellas Pharma Inc.
AstraZeneca
BeiGene USA
Bristol-Myers Squibb Company
Daiichi Sankyo, Inc.
Eisai, Inc.
Eli Lilly and Company
GlaxoSmithKline
Legend Biotech USA Inc.
Merck Sharp & Dohme Corp